[A case of chronic pyopolypous pansinusitis with mucopyocele of the frontal sinus].

Chronic pyopolypous pansinusitis in a patient presenting with mucopyocele of the frontal sinus is described. A brief characteristic of cyst-like extension of the paranasal sinuses is presented. Special attention is given to the main diagnostic criteria.

[Combined local therapy in oropharyngeal diseases].

A pilot trial of efficacy of the drugs lisobact and stomatidin in local treatment of acute pharyngitis and combined therapy of tonsillitis and paratonsillar abscess included 82 patients with tonsillitis (n=30), paratonsillar abscess (n=30) and acute pharyngitis (n=22) aged 15-72 years. Effectiveness of the treatment was assessed by changes in clinical symptoms, pharyngoscopic picture and results of bacteriological studies. It was found that treatment with lisobact and stomatidin diminished considerably bacterial contamination of the paratonsillar abscess and pharyngeal mucosa.

[New perspectives in non-invasive treatment of sinusitis].

A randomized multicenter study of sinuforte efficacy and safety was made in 120 patients with sinusitis. All the patients were randomized into two groups: the study group of 60 patients received monotherapy with sinuforte in a single daily dose for 7 days; the control group of 60 patients received conventional treatment for 7 days. The efficacy of the treatments was assessed by the results of clinical, endoscopic and laboratory tests.

[Variants of plastic operations on the anterior wall of the frontal sinus].

Variants of plastic reconstruction of the frontal sinus anterior wall in its traumatic lesion is reviewed. Examination and treatment of 17 patients with the diagnosis of fracture of the frontal sinus anterior wall with a cosmetic defect were performed in Moscow hospital N 1. Plastic reconstruction consisted of reposition of the bone fragments with elevator (6 patients), reposition and suturing of the fragments to the border of the bone defect (9 patients).

[A comparative analysis of antibiotics efficacy in acute ENT infections].

The comparison of the efficacy of a number of antibacterial drugs in acute pyoinflammatory ENT diseases allowed the authors to recommend moxifloxacin as most effective in acute purulent ENT pathology. Moxifloxacin demonstrated its superiority in seeding (the highest sensitivity of the bacteria to this antibiotic), in the speed of development of the bactericidal action and in treatment results. The drug had no significant side effects.